Achieve Life Sciences, Inc.
ACHV · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $161 | $78 | $93 | $121 |
| - Cash | $32 | $52 | $13 | $13 |
| + Debt | $10 | $10 | $10 | $10 |
| Enterprise Value | $139 | $36 | $90 | $119 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$14 | -$12 | -$13 | -$12 |
| % Margin | – | – | – | – |
| Net Income | -$14 | -$13 | -$13 | -$12 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.28 | -0.37 | -0.37 | -0.36 |
| % Growth | 24.3% | 0% | -2.8% | – |
| Operating Cash Flow | -$11 | -$9 | -$11 | -$9 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$11 | -$9 | -$11 | -$9 |